Literature DB >> 16931104

Cross-cultural evaluation of the short form 8-item Parkinson's Disease Questionnaire (PDQ-8): results from America, Canada, Japan, Italy and Spain.

Crispin Jenkinson1, Ray Fitzpatrick.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the psychometric properties of a short form health survey, the Parkinson's Disease Questionnaire (PDQ-8), cross-culturally, by comparing results gained from this instrument to the original longer form instrument-the PDQ-39.
DESIGN: Data are from the Global Parkinson's Disease Survey. OUTCOMES: The 8-item Parkinson's Disease Questionnaire Single Index Score (PDQ-8-SI). In this study, we evaluate response rate, scaling assumptions, and data quality, in terms of comparability of results with the parent form from which the PDQ-8 was derived, of the instrument in the USA, Canada, Spain, Italy and Japan.
RESULTS: The PDQ-8 was found to produce results that were very similar to the parent form across all five countries. However, it should be borne in mind that the PDQ-8 was nested within the PDQ-39, and results may be influenced by this.
CONCLUSIONS: Results suggest that the PDQ-8 is a valid and reliable measure that can be appropriately and meaningfully used in cross-cultural studies.

Entities:  

Mesh:

Year:  2006        PMID: 16931104     DOI: 10.1016/j.parkreldis.2006.06.006

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  35 in total

1.  The 39-Item Parkinson's Disease Questionnaire (PDQ-39): Is it a Unidimensional Construct?

Authors:  Peter Hagell; Maria H Nilsson
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

2.  Quality of life in Parkinson's disease patients: validation of the Short-Form Eight-item Parkinson's Disease Questionnaire (PDQ-8) in Taiwan.

Authors:  Tzu-Ting Huang; Hua-Yun Hsu; Bi-Hwa Wang; Kang-Hua Chen
Journal:  Qual Life Res       Date:  2010-10-24       Impact factor: 4.147

3.  Mapping the eight-item Parkinson's Disease Questionnaire (PDQ-8) to the EQ-5D utility index.

Authors:  Y B Cheung; L C S Tan; P N Lau; W L Au; N Luo
Journal:  Qual Life Res       Date:  2008-09-20       Impact factor: 4.147

4.  Psychometric Properties of Activity, Self-Efficacy, and Quality-of-Life Measures in Individuals with Parkinson Disease.

Authors:  Vanina Dal Bello-Haas; Laura Klassen; M Suzanne Sheppard; Amy Metcalfe
Journal:  Physiother Can       Date:  2011-01-20       Impact factor: 1.037

5.  Homotaurine in Parkinson's disease.

Authors:  Lucia Ricciardi; Francesca De Nigris; Alessandro Specchia; Alfonso Fasano
Journal:  Neurol Sci       Date:  2015-04-19       Impact factor: 3.307

6.  Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson's disease population sample.

Authors:  Miguel Ángel García-Gordillo; Borja del Pozo-Cruz; José Carmelo Adsuar; Fernando Ignacio Sánchez-Martínez; José María Abellán-Perpiñán
Journal:  Qual Life Res       Date:  2013-11-22       Impact factor: 4.147

7.  Rasch analysis of the short form 8-item Parkinson's Disease Questionnaire (PDQ-8).

Authors:  Franco Franchignoni; Andrea Giordano; Giorgio Ferriero
Journal:  Qual Life Res       Date:  2008-05       Impact factor: 4.147

Review 8.  Impact of newer pharmacological treatments on quality of life in patients with Parkinson's disease.

Authors:  David A Gallagher; Anette Schrag
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

9.  The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease.

Authors:  Matthew Menza; Roseanne DeFronzo Dobkin; Humberto Marin; Margery H Mark; Michael Gara; Steven Buyske; Karina Bienfait; Allison Dicke
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338

10.  Validity and Reliability of the Turkish Version of the 8-Item Parkinson's Disease Questionnaire.

Authors:  Turhan Kahraman; Arzu Genç; Fatih Söke; Evrim GÖz; Berril Dönmez Çolakoğlu; Pembe Keskįnoğlu
Journal:  Noro Psikiyatr Ars       Date:  2018-07-12       Impact factor: 1.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.